| Revised adult T-cell leukemia-lymphoma international consensus meeting report LB Cook, S Fuji, O Hermine, A Bazarbachi, JC Ramos, L Ratner, ... Journal of Clinical Oncology 37 (8), 677-687, 2019 | 214 | 2019 |
| Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia/lymphoma is associated with significantly increased risks of severe and corticosteroid … S Fuji, Y Inoue, A Utsunomiya, Y Moriuchi, K Uchimaru, I Choi, E Otsuka, ... Journal of Clinical Oncology 34 (28), 3426-3433, 2016 | 171 | 2016 |
| Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality S Fuji, T Mori, N Khattry, J Cheng, YR Do, K Yakushijin, S Kohashi, ... Bone marrow transplantation 50 (1), 100-105, 2015 | 107 | 2015 |
| Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation S Fuji, SW Kim, S Mori, T Fukuda, S Kamiya, S Yamasaki, Y Morita-Hoshi, ... Transplantation 84 (7), 814-820, 2007 | 106 | 2007 |
| Systematic nutritional support in allogeneic hematopoietic stem cell transplant recipients S Fuji, H Einsele, BN Savani, M Kapp Biology of Blood and Marrow Transplantation 21 (10), 1707-1713, 2015 | 103 | 2015 |
| Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT S Fuji, K Takano, T Mori, T Eto, S Taniguchi, K Ohashi, H Sakamaki, ... Bone marrow transplantation 49 (12), 1505-1512, 2014 | 101 | 2014 |
| Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation Y Tanaka, S Kurosawa, K Tajima, T Tanaka, R Ito, Y Inoue, K Okinaka, ... Bone marrow transplantation 51 (4), 553-559, 2016 | 81 | 2016 |
| Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation T Tanaka, Y Inamoto, T Yamashita, S Fuji, K Okinaka, S Kurosawa, ... Biology of Blood and Marrow Transplantation 22 (5), 919-924, 2016 | 79 | 2016 |
| Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease S Fuji, SW Kim, K Yoshimura, H Akiyama, S Okamoto, H Sao, J Takita, ... Biology of Blood and Marrow Transplantation 15 (1), 73-82, 2009 | 76 | 2009 |
| Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation S Fuji, SW Kim, T Fukuda, S Mori, S Yamasaki, Y Morita-Hoshi, ... Biology of Blood and Marrow Transplantation 14 (5), 510-517, 2008 | 62 | 2008 |
| Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma S Fuji, H Fujiwara, N Nakano, A Wake, Y Inoue, T Fukuda, M Hidaka, ... Bone marrow transplantation 51 (2), 205-211, 2016 | 57 | 2016 |
| Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen B Saito, T Fukuda, H Yokoyama, S Kurosawa, T Takahashi, S Fuji, ... Biology of Blood and Marrow Transplantation 14 (10), 1148-1155, 2008 | 55 | 2008 |
| Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of … S Fuji, F Nakamura, K Hatanaka, S Taniguchi, M Sato, S Mori, ... Biology of Blood and Marrow Transplantation 18 (9), 1407-1414, 2012 | 54 | 2012 |
| Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies … S Fuji, T Yamaguchi, Y Inoue, A Utsunomiya, Y Moriuchi, K Uchimaru, ... Haematologica 102 (7), 1258, 2017 | 52 | 2017 |
| Chimeric antigen receptor T-cells for the treatment of B-cell acute lymphoblastic leukemia C Tomuleasa, S Fuji, C Berce, A Onaciu, S Chira, B Petrushev, WT Micu, ... Frontiers in Immunology 9, 239, 2018 | 51 | 2018 |
| Association of cumulative steroid dose with risk of infection after treatment for severe acute graft-versus-host disease Y Matsumura-Kimoto, Y Inamoto, K Tajima, A Kawajiri, T Tanaka, ... Biology of Blood and Marrow Transplantation 22 (6), 1102-1107, 2016 | 50 | 2016 |
| CD48 as a novel molecular target for antibody therapy in multiple myeloma N Hosen, H Ichihara, A Mugitani, Y Aoyama, Y Fukuda, S Kishida, ... British journal of haematology 156 (2), 213-224, 2012 | 49 | 2012 |
| Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma S Fuji, T Shindo Stem Cell Investigation 3, 2016 | 46 | 2016 |
| Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation H Nakasone, F Shigeo, K Yakushijin, M Onizuka, A Shinohara, K Ohashi, ... American Journal of Hematology 92 (2), 171-178, 2017 | 45 | 2017 |
| Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality Y Inoue, S Fuji, R Tanosaki, T Fukuda Bone Marrow Transplantation 51 (5), 725-727, 2016 | 41 | 2016 |
